Purdue Pharma Cuts Rest of Its Sales Force in Opioids Pullback - Bloomberg
▻https://www.bloomberg.com/news/articles/2018-06-20/purdue-pharma-cuts-rest-of-its-sales-force-in-opioids-pullback
Oxycontin-maker Purdue Pharma LP cut the remainder of its sales force this week, the latest move by the company to distance itself from opioids as it faces accusations that it contributed to the nation’s addiction crisis.
The Stamford, Connecticut-based drugmaker said it will retain about 550 employees after chopping around 350 positions, including about 250 employees focused on promoting the treatment for opioid-induced constipation, Symproic. That product launched last year in partnership with Japan-based Shionogi & Co. The other employees worked in the company’s headquarters.